Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Rachael Bashford-Rogers

Dr Rachael Bashford-Rogers

Contact information

Email
rbr1@well.ox.ac.uk

Research groups

Bashford-Rogers: From adaptive immunity to clinical translation

Rachael Bashford-Rogers

Group leader/PI

Recent publications

Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal adenocarcinoma (PDAC): a nested case-control study.
Journal article

Tan PS. et al, (2022), Gut
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Journal article

Ahern DJ. et al, (2022), Cell, 185, 916 - 938.e58
B cell receptor repertoire kinetics after SARS-CoV-2 infection and vaccination
Journal article

Kotagiri P. et al, (2022), Cell Reports, 38
An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease
Journal article

Peng Y. et al, (2022), Nature Immunology, 23, 50 - 61
Clonally Expanded B Cells in Multiple Sclerosis Bind EBV EBNA1 and GlialCAM
Journal article

Lanz TV. et al, (2022), Nature

More publications